The 2023 Q3 earnings season kicks off tomorrow with major U.S. banks leading the way Despite the bleak backdrop, S&P 500's Q3 earnings outlook is not as bad as expected This...
U.S. jobs report, ISM PMI surveys, more earnings in focus. Apple shares are a buy with fiscal Q3 results due on Thursday. Pfizer’s stock is set to struggle amid shrinking...
Earnings season continues, with healthcare companies set to report next week Among them is Pfizer, whose stock has corrected significantly of late Based on the company's strong...
August is expected to be another volatile month on Wall Street amid a plethora of market-moving events. Investor focus will be on the U.S. jobs report, CPI inflation data, the...
Tech-savvy millennials are very active stock market participants At times, they tend to double the trading volume of older generations Using InvestingPro, let's take a look at some...
Fed rate hike, Powell comments, U.S. jobs report, and more earnings will drive sentiment this week. Apple stock is a buy with earnings due on Thursday. AMD shares are a sell amid...
May is expected to be another volatile month on Wall Street. Investor focus will be on the Federal Reserve’s policy meeting, the monthly jobs report, inflation data, more...
Moderna (NASDAQ:MRNA) shares closed lower on Tuesday after the vaccine maker said that its vaccine against seasonal flu did not achieve “early success” in the Phase 3...
In 2022, the vast majority of hedge funds struggled to generate returns for their investors. As stock-picking funds generated negative returns, global macro funds came out the big...
Biotech company Moderna (NASDAQ:MRNA) is seeing its shares trade under pressure in recent days after the company reported last week Phase 3 trial results for its flu vaccine...